Why the study?
The study aimed to estimate the prevalence of HF with preserved ejection fraction (HF-PEF) among Saudi outpatients with HF and compare their clinical characteristics to those with reduced ejection fraction.
In a Saudi outpatient cohort, HFpEF accounted for approximately half of heart failure cases with documented ejection fraction.
HFpEF comprises half of HF cases in Saudi outpatients; extends observational epidemiology but leaves generalizability and practice implications open.
Objective: The present study aims to estimate the prevalence of heart failure (HF) with preserved ejection fraction (HF-PEF) in patients with HF. The study also compares their clinical characteristics with heart failure and reduced ejection fraction among Saudi out patients. Methods: A Cross sectional, observational study was conducted by recruiting heart failure patients, who had an echocardiography within one year and the left ventricular ejection fraction >45%. The case report forms monitored for source documentation and accuracy. Results: The population sample included 26% women; with mean age 58 ±10 years (range 32 to 82). Of these patients, 66 did not have an EF measurement. Of the 330 patients with EF values, 168 had an EF of >45% and were classified as having HF-PEF and 162 had an EF < 45% and were classified as having HF-REF. Calcium channel blocker, thiazides diuretic and ARBs were more frequently used in HF-PEF. Conclusion: The study concluded that there is a need to develop safe and cost-effective methods for screening high-risk patients with multiple risk factors for the early detection and treatment of heart failure.
No takes yet. Share an insight, caveat, or question.
Shamiri et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: